The sweet side of tumor immunotherapy.

Abstract : Carbohydrate signatures on tumor cells have functional implications in tumor growth and metastasis and constitute valuable tools in cancer diagnosis and immunotherapy. Increasing data regarding the mechanisms by which they are recognized by the immune system are facilitating the design of more efficient immunotherapeutic protocols based on cancer-associated glycan structures. Recent molecular and proteomic studies revealed that carbohydrates are recognized, not only by B cells and antibodies, but also by cells from the innate arm of immunity, as well as by T cells, and are able to induce specific T-cell immunity and cytotoxicity. In this review, we discuss and update the different strategies targeting tumor-associated carbohydrate antigens that are being evaluated for antitumor immunotherapy, an approach that will be highly relevant, especially when combined with other strategies, in the future fight against cancer.
Document type :
Journal articles
Complete list of metadatas

Cited literature [102 references]  Display  Hide  Download

https://hal-riip.archives-ouvertes.fr/pasteur-00844603
Contributor : Mariella Botta <>
Submitted on : Monday, July 15, 2013 - 3:44:34 PM
Last modification on : Monday, August 12, 2019 - 5:38:03 PM
Long-term archiving on : Wednesday, April 5, 2017 - 11:21:39 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Teresa Freire, Eduardo Osinaga. The sweet side of tumor immunotherapy.. Immunotherapy, Future Medicine, 2012, 4 (7), pp.719-34. ⟨10.2217/imt.12.58⟩. ⟨pasteur-00844603⟩

Share

Metrics

Record views

88